SPP1 and cancer: Dysregulation of the glyco-phosphoprotein osteopontin (OPN)/SPP1 has been implicated in various cancers [12], including specific types of lymphoma (e.g., large B-cell lymphoma, ALK-positive anaplastic large-cell lymphoma) [13,14,15].